Unknown

Dataset Information

CX-5461 induces radiosensitization through modification of the DNA damage response and not inhibition of RNA polymerase I.


ABSTRACT: Increased ribosome biogenesis is a distinguishing feature of cancer cells, and small molecule inhibitors of ribosome biogenesis are currently in clinical trials as single agent therapy. It has been previously shown that inhibiting ribosome biogenesis through the inhibition of nuclear export of ribosomal subunits sensitizes tumor cells to radiotherapy. In this study, the radiosensitizing potential of CX-5461, a small molecule inhibitor of RNA polymerase I, was tested. Radiosensitization was measured by clonogenic survival assay in a panel of four tumor cell lines derived from three different tumor types commonly treated with radiation. 50 nM CX-5461 radiosensitized PANC-1, U251, HeLa, and PSN1 cells with dose enhancement factors in the range of 1.2-1.3. However, 50 nM CX-5461 was not suffic

SUBMITTER: Lehman SL 

PROVIDER: S-EPMC8904802 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature